Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 2
2011 1
2013 1
2014 1
2017 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Related Articles by Review for PMID: 29261922

10 results

Results by year

Filters applied: . Clear all
Page 1
Warfarin.
Patel S, Singh R, Preuss CV, Patel N. Patel S, et al. 2023 Mar 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Mar 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29261922 Free Books & Documents.
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA, Bodalia PN, Bryden PA, Davies PA, López-López JA, Okoli GN, Thom HH, Caldwell DM, Dias S, Eaton D, Higgins JP, Hollingworth W, Salisbury C, Savović J, Sofat R, Stephens-Boal A, Welton NJ, Hingorani AD. Sterne JA, et al. Health Technol Assess. 2017 Mar;21(9):1-386. doi: 10.3310/hta21090. Health Technol Assess. 2017. PMID: 28279251 Free PMC article. Review.
Ximelagatran.
Choudhury A, Goyal D, Lip GY. Choudhury A, et al. Drugs Today (Barc). 2006 Jan;42(1):3-19. doi: 10.1358/dot.2006.42.1.893611. Drugs Today (Barc). 2006. PMID: 16511607 Review.
Anticoagulants for people hospitalised with COVID-19.
Flumignan RL, Civile VT, Tinôco JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah ÁN, Nakano LC. Flumignan RL, et al. Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2. Cochrane Database Syst Rev. 2022. PMID: 35244208 Free PMC article. Review.
Coumarin therapy in thrombosis.
Pineo G, Hull RD. Pineo G, et al. Hematol Oncol Clin North Am. 2003 Feb;17(1):201-16, viii. doi: 10.1016/s0889-8588(02)00087-4. Hematol Oncol Clin North Am. 2003. PMID: 12627669 Review.
Ximelagatran: direct thrombin inhibitor.
Ho SJ, Brighton TA. Ho SJ, et al. Vasc Health Risk Manag. 2006;2(1):49-58. doi: 10.2147/vhrm.2006.2.1.49. Vasc Health Risk Manag. 2006. PMID: 17319469 Free PMC article. Review.
Ximelagatran: a new oral anticoagulant.
Hrebickova L, Nawarskas JJ, Anderson JR. Hrebickova L, et al. Heart Dis. 2003 Nov-Dec;5(6):397-408. doi: 10.1097/01.hdx.0000099777.39577.e8. Heart Dis. 2003. PMID: 14633322 Review.
Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions.
Sarich TC, Peters G, Berkowitz SD, Misselwitz F, Nessel CC, Burton P, Cook-Bruns N, Lensing AW, Haskell L, Perzborn E, Kubitza D, Moore KT, Jalota S, Weber J, Pan G, Sun X, Westermeier T, Nadel A, Oppenheimer L, DiBattiste PM. Sarich TC, et al. Ann N Y Acad Sci. 2013 Jul;1291:42-55. doi: 10.1111/nyas.12136. Epub 2013 May 23. Ann N Y Acad Sci. 2013. PMID: 23701516 Review.